BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/4/2026 12:06:31 PM | Browse: 6 | Download: 0
Publication Name World Journal of Diabetes
Manuscript ID 117228
Country China
Category Dermatology
Manuscript Type Editorial
Article Title Fractional carbon dioxide laser preconditioning potentiates adipose-derived mesenchymal stem cell exosomes for diabetic wound repair
Manuscript Source Invited Manuscript
All Author List Chun-Yi Wu, Xie-Hua Xiao and Jian-Guo Feng
Funding Agency and Grant Number
Funding Agency Grant Number
Sichuan Science and Technology Program No. 2025ZNSFSC0744
Health Commission of Sichuan Province Medical Science and Technology Program No. 24QNMP040
Luzhou Science and Technology Program No. 2025RCX002
Corresponding Author Jian-Guo Feng, Associate Professor, PhD, Principal Investigator, Department of Anesthesiology, The Affiliated Hospital, Southwest Medical University, No.25th, Taiping Street, Luzhou, Luzhou 646000, Sichuan Province, China. fengjianguo@swmu.edu.cn
Key Words Angiogenesis.; Preconditioning; Fractional carbon dioxide laser; Exosomes; Mesenchymal stem cells; Diabetic wound healing
Core Tip This editorial highlight that fractional carbon dioxide (CO₂) laser pre-conditioning offers a novel, drug-free strategy to enhance the therapeutic quality of adipose-derived mesenchymal stem cell exosomes (Exos) for diabetic wound repair. We emphasize recent findings that this physical pre-conditioning strategy, utilizing clinically established and dose-tunable photothermal stimulation, enriches sphingosine-1-phosphate (S1P) cargo and activates endothelial S1P receptor 1/protein kinase B/hypoxia-inducible factor-1α signaling, thereby promoting improved angiogenesis and cytoprotection. This concept reframes fractional CO₂ lasers as a scalable, good manufacturing practice-compatible platform to “upgrade” Exos bioactivity for chronic diabetic wounds.
Citation Wu CY, Xiao XH, Feng JG. Fractional carbon dioxide laser preconditioning potentiates adipose-derived mesenchymal stem cell exosomes for diabetic wound repair. World J Diabetes 2026; In press
Received
2025-12-02 00:57
Peer-Review Started
2025-12-03 09:18
First Decision by Editorial Office Director
2025-12-31 07:54
Return for Revision
2025-12-31 07:54
Revised
2026-01-14 03:34
Publication Fee Transferred
Second Decision by Editor
2026-02-04 02:48
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-04 12:06
Articles in Press
2026-02-04 12:06
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com